NCT02130804View on ClinicalTrials.gov

Using Salsalate to Target Adipocyte Macrophage Infiltration

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Diabetes Risk
Interventions
DRUG

Salsalate (4 g/day)

Given orally twice daily

DRUG

Placebo (4 g/day)

Given orally twice daily

Trial Locations (2)

90089

University of Southern California Diabetes Obesity Research Institute (DORI), Los Angeles

University of Southern California, Clinical Trials Unit (CTU), Los Angeles

All Listed Sponsors
lead

University of Southern California

OTHER

NCT02130804 - Using Salsalate to Target Adipocyte Macrophage Infiltration | Biotech Hunter | Biotech Hunter